Scientists at a private company say they have completed the first successful gene therapy against aging. How is that for a claim! The CEO of BioViva Sciences, acting as the proverbial guinea pig, asserts she is the first person in history to demonstrate a reversal of natural aging using an experimental gene therapy technique developed by her company. The claim has yet to be peer reviewed, but it’s exciting nonetheless, because if it’s verified, it’s nothing short of revolutionary.

The marker they are using for aging is telomere shortening. Telomeres naturally shorten as we age, and after a predetermined amount of replications known as the Hayflick Limit, they lose their ability to complete the process of DNA replication which leads to cellular malfunctioning and dormancy, (senescence) and eventually cellular death, (apoptosis). Telomere length was measured before and after the proprietary gene therapy in white blood cells (T-lymphocytes). Compared against the average telomere length in white blood cells within the same age range as the CEO (44 years old), the company claims that the treatment, reputed to be safe, showed that it reversed 20 years of telomere shortening. Read the article HERE. And find out more about telomeres HERE and gene therapy HERE. This is promising indeed. Time for me to test my own telomere length using this test HERE.

Author: Vic Love, www.Fb.com/Vityalove